Increasing the Robustness of Biopharmaceutical Precipitation Assays - Part II: Recommendations on the use of FaSSIF

Katharina Krollik1, Andreas Lehmann2, Christian Wagner2

  • 1Institute of Pharmacy, Department of Biopharmaceutics and Pharmaceutical Technology, University of Greifswald, Felix-Hausdorff-Straße 3, Greifswald, Germany; Chemical and Pharmaceutical Development, Merck KGaA, Frankfurter Strasse 250, Darmstadt, Germany.

Related Concept Videos